2023
DOI: 10.1016/j.isci.2023.106245
|View full text |Cite
|
Sign up to set email alerts
|

Centrifugal microfluidic-based multiplex recombinase polymerase amplification assay for rapid detection of SARS-CoV-2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0
1

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 53 publications
0
6
0
1
Order By: Relevance
“…A centrifugal microfluidic platform was proposed to detect SARS-CoV-2 rapidly [62]. A multiplex assay targeting the E, N, and ORF1ab genes of SARS-CoV-2 was realized using RT-RPA and fluorescence monitoring.…”
Section: Fluorescence-based Detection Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…A centrifugal microfluidic platform was proposed to detect SARS-CoV-2 rapidly [62]. A multiplex assay targeting the E, N, and ORF1ab genes of SARS-CoV-2 was realized using RT-RPA and fluorescence monitoring.…”
Section: Fluorescence-based Detection Methodsmentioning
confidence: 99%
“…In the future, integrating sample preparation on a chip platform should be performed. Secondly, high-throughput screening for targets remained limited [62]. Figure 4 illustrates the strategy for using centrifugal microfluidic devices to detect multiple SARS-CoV-2 genes.…”
Section: Fluorescence-based Detection Methodsmentioning
confidence: 99%
“…Additionally, 3D bioprinting offers a promising solution for large-scale tissue construction, blood vessel maturation, organ transplantation, and regeneration research [ 80 , 139 , 140 ]. Integrating biosensors, multiplex, and artificial intelligence setups into chips can provide real-time online monitoring of the behavior of SARS-CoV2, including viral infection and transmission, microenvironment changes, and organ function [ 141 , 142 ]. Finally, on-chip multi-omics and high-resolution imaging devices can be used to analyze ultra-early-stage viral infection detection, virus screening, organopathy, and secondary and systemic diseases [ [143] , [144] , [145] ].…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%
“…Для обнаружения SARS-CoV-2 предложен чип на основе центробежной микрофлюидики, сочетающий ОТ-РПА и флуоресцентную детекцию по конечной точке [62]. Микрофлюидный чип в форме предметного стекла для микроскопа позволял одновременно обнаруживать наличие 3 вирусных мишеней и 1 мишень ДНК человека за 30 мин.…”
Section: автономные портативные устройстваunclassified